17.06.2016 • NewsDede WillamsParticle SciencesLubrizol

Particle Sciences Adds Filling Capacity

Drug product formulation specialist Particle Sciences, part of Lubrizol’s LifeSciences business since September 2015, has added capacity for cGMP sterile powder filling and capsule filling. The company said the expansion is in response to customer demand. In particular, it said, “there has been an uptick in our partners’ need for sterile powder filling, both in vials and proprietary devices.”

To meet the need, Particle Sciences said it has added equipment that allows powder fills from 50 mg to 75 g, with an accuracy of up to +/- 1% of fill volume, including those for highly potent compounds.

Also included in the expansion is capsule filling.  With a clinical supply capability of 3,000 capsules (sizes 0- 4) per hour, the company said it is positioned to assist clients in utilizing its bioavailability-enhancing platforms in oral dosage forms.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.